Avigan could be formally approved as Ebola drug early 2015
TOKYO, Japan - Shigetaka Komori, chief executive officer of Fujifilm Holdings Corp., attends a press conference in Tokyo, Japan, on Nov. 11, 2014, announcing that the company expects its Avigan anti-influenza drug to be formally approved early next year for treating people infected with the Ebola virus. (Kyodo)
- Product Code
- ILEA000338259
- Registered date
- 2014/11/11 00:00:00
- Credit
- Kyodo / Kyodo News Images
- Media size
- 605 × 803 pixel
- Deployment size
- 122.00(KB)*
*File size when opened in Photoshop, etc.